Literature DB >> 28843905

Role of neuropilin-2 in the immune system.

S Schellenburg1, A Schulz1, D M Poitz2, M H Muders3.   

Abstract

Neuropilins (NRPs) are single transmembrane receptors with short cytoplasmic tails and are dependent on receptors like VEGF receptors or Plexins for signal transduction. NRPs are known to be important in angiogenesis, lymphangiogenesis, and axon guidance. The Neuropilin-family consists of two members, Neuropilin-1 (NRP1) and Neuropilin-2 (NRP2). They are up to 44 % homologous and conserved in all vertebrates. High levels of NRP2 are found on immune cells. Current research is very limited regarding the functions of NRP2 on these cells. Recent evidence suggests that NRP2 is important for migration, antigen presentation, phagocytosis and cell-cell contact within the immune system. Additionally, posttranslational NRP2 modifications like polysialylation are crucial for the function of some immune cells. This review is an overview about expression and functions of NRP2 in the immune system.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neuropilin-2; Polysialylation

Mesh:

Substances:

Year:  2017        PMID: 28843905     DOI: 10.1016/j.molimm.2017.08.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

1.  Neuropilin-2 regulates airway inflammatory responses to inhaled lipopolysaccharide.

Authors:  Robert M Immormino; David C Lauzier; Hideki Nakano; Michelle L Hernandez; Neil E Alexis; Andrew J Ghio; Stephen L Tilley; Claire M Doerschuk; David B Peden; Donald N Cook; Timothy P Moran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-19       Impact factor: 5.464

2.  Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies.

Authors:  Elmira Karami; Shamsi Naderi; Reyhaneh Roshan; Mahdi Behdani; Fatemeh Kazemi-Lomedasht
Journal:  Cancer Chemother Pharmacol       Date:  2022-01-06       Impact factor: 3.288

3.  Roles for VEGF-C/NRP-2 axis in regulating renal tubular epithelial cell survival and autophagy during serum deprivation.

Authors:  Xiaoyan Chang; Qian Yang; Conghui Zhang; Ying Zhang; Xinjun Liang; Yanyan Liu; Gang Xu
Journal:  Cell Biochem Funct       Date:  2019-06       Impact factor: 3.685

Review 4.  Semaphorin 3F and Netrin-1: The Novel Function as a Regulator of Tumor Microenvironment.

Authors:  Hironao Nakayama; Chiaki Kusumoto; Masako Nakahara; Akira Fujiwara; Shigeki Higashiyama
Journal:  Front Physiol       Date:  2018-11-23       Impact factor: 4.566

5.  Hes1 attenuates type I IFN responses via VEGF-C and WDFY1.

Authors:  Fei Ning; Xiaoyu Li; Li Yu; Bin Zhang; Yuna Zhao; Yu Liu; Baohong Zhao; Yingli Shang; Xiaoyu Hu
Journal:  J Exp Med       Date:  2019-04-23       Impact factor: 14.307

Review 6.  Neuropilins in the Context of Tumor Vasculature.

Authors:  Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

7.  Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies.

Authors:  Suman Pokhrel; Benjamin R Kraemer; Scott Burkholz; Daria Mochly-Rosen
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

Review 8.  Emerging Roles for Neuropilin-2 in Cardiovascular Disease.

Authors:  Jennifer L Harman; Jacob Sayers; Chey Chapman; Caroline Pellet-Many
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 6.208

9.  Exploring rare and low-frequency variants in the Saguenay-Lac-Saint-Jean population identified genes associated with asthma and allergy traits.

Authors:  Andréanne Morin; Anne-Marie Madore; Tony Kwan; Maria Ban; Jukka Partanen; Lars Rönnblom; Ann-Christine Syvänen; Stephen Sawcer; Hendrik Stunnenberg; Mark Lathrop; Tomi Pastinen; Catherine Laprise
Journal:  Eur J Hum Genet       Date:  2018-09-11       Impact factor: 4.246

10.  miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.

Authors:  Mingchuan Zhao; Mengmeng Zhang; Zhonghua Tao; Jun Cao; Leiping Wang; Xichun Hu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.